Cardiology (HTN, Angina, some HF) Drugs Flashcards
HTN w/ Diabetes
ACE inhibitors/ARBs are protective against diabetic neuropathy
HTN in pregnancy
Hydralazine, labetalol, methyldopa, nifedipine
Ca Channel Blockers - Dihydropyridines
Amlodipine, clevidipine, nicardipine, nifedipine, nimodipine = - dipines
Act on VASCULAR SMOOTH MUSCLE
AE: peripheral edema, flushing, dizziness, gingival hyperplasia
Ca Channel Blockers - Nondihydropyridines
Diltiazem, verapamil (verapamil - ventricle = strongest heart drug)
Act on HEART
AE: cardiac depression, AV block, hyperprolactinemia, constipation
Ca Channel Blockers - MOA
Block VG (L-type) Ca channels of cardiac/smooth muscle Decrease muscle contractility
Nimodipine CU
subarachnoid hemorrhage (prevents cerebral vasospasm)
Clevidipine CU
hypertensive emergency
Dihydropyridines CU
(except nimodipine)
HTN, angina (including Prinzmetal), Raynaud phenomenon
VASCULAR SM EFFECTS
Non-dihydropyridines CU
HTN, angina, atrial fibrillation/flutter
HEART EFFECTS
Hydralazine
Increase cGMP - SM relaxation / vasodilation
ARTERIOLES > Veins
Reduces AFTERLOAD- frequently give w/B blocker to prevent reflex tachycardia
CU: acute severe HTN, HF (w/organic nitrate)
Safe in pregnancy
CI: angina/CAD bc compensatory tachycardia effects
AE: fluid retention, HA, angina, Lupus-like syndrome
HTN emergency drugs
Clevidipine/Nicardipine (Dihydropine Ca channel blockers)
Fenoldopam
Nitroprusside
Labetalol
Nitroprusside
Direct release of NO to increase cGMP - vasodilation
CU: HTN emergency (short acting)
AE: cyanide toxicity (releases cyanide)
Fenoldopam
DA D1 R agonist
Coronary, peripheral, renal and splanchnic vasodilation
Decreases BP, increases natriuresis (Na excretion)
CU: HTN emergency, post-op antihypertensive
AE: hypotension, tachycardia
Nitrates
nitroglycerin, isosorbide dinitrate, isosorbide mononitrate
MOA: Increase NO in vascular SM - increase cGMP - SM relaxation/vasodilation
VEINS»»arterioles - decrease PRELOAD
CU: angina, acute coronary syndrome, pulmonary edema
AE: reflex tachycardia (Tx w/B blocker), hypotension, dizziness, flushing, HA
“Monday dz” in industrial exposure (tolerance for vasodilation action develops during work week, but is lost over weekend (increased AE’s))
Goal of Antianginal Therapy
Reduction of myocardial O2 consumption (MVO2) by decreasing one or more determinants (end-diastolic volume, BP, HR, contractility)
Best combo antianginal therapy = Nitrates + B-blockers